Sanaz Memarzadeh, Ph.D.
Affiliations: | 2008 | University of California, Los Angeles, Los Angeles, CA |
Area:
Molecular BiologyGoogle:
"Sanaz Memarzadeh"Parents
Sign in to add mentorOwen N. Witte | grad student | 2008 | UCLA | |
(The role of CSF and FGF receptors in prostate cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Moatamed NA, Vahdatshariatpanahi S, Gjertson DW, et al. (2023) Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers. Plos One. 18: e0291361 |
Singh T, Neal A, Dibernardo G, et al. (2022) Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers. International Journal of Oncology. 60 |
Neal A, Lai T, Singh T, et al. (2021) Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers. Cancers. 13 |
Neal AS, Nunez M, Lai T, et al. (2020) Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia. Reproductive Sciences (Thousand Oaks, Calif.) |
Gilbert L, Oaknin A, Matulonis UA, et al. (2020) Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer. Journal of Clinical Oncology. 38: 6004-6004 |
Lai T, Neal A, Grogan T, et al. (2019) A novel peptide that restores p53 function may act synergistically with carboplatin in targeting high-grade serous ovarian cancers Gynecologic Oncology. 154: 254 |
La V, Fujikawa R, Janzen D, et al. (2016) Abstract LB-131: Birinapant and carboplatin co-therapy can effectively target platinum resistant ovarian cancer initiating cells Cancer Research. 76 |
Soragni A, Janzen DM, Johnson LM, et al. (2015) A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer Cell |
Janzen DM, Tiourin E, Salehi JA, et al. (2015) An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer. Nature Communications. 6: 7956 |
Tiourin E, Velasco VS, Rosales MA, et al. (2015) Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria. Reproductive Sciences (Thousand Oaks, Calif.) |